STOCK TITAN

[Form 4] Sharps Technology Inc. Warrant Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Brenda Baird Simpson, a director of Sharps Technology Inc. (ticker: STSSW), was granted a non‑derivative option to purchase 20,000 shares on 08/22/2025 at an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and "will become 100% vested as of the date of issuance," per the filing. Following the grant, Ms. Simpson directly beneficially owns 20,000 shares/options reported on this Form 4.

Brenda Baird Simpson, membro del consiglio di amministrazione di Sharps Technology Inc. (ticker: STSSW), ha ricevuto in data 22/08/2025 un’opzione non derivativa per acquistare 20.000 azioni al prezzo di esercizio di $6,41 per azione. L’opzione è stata concessa nell’ambito del Piano di Incentivazione Azionaria 2025 della società e, secondo il deposito, "diventerà completamente vestita alla data di emissione". Dopo la concessione, la Sig.ra Simpson detiene direttamente la proprietà beneficiaria di 20.000 azioni/opzioni riportate in questo Modulo 4.

Brenda Baird Simpson, directora de Sharps Technology Inc. (símbolo: STSSW), recibió el 22/08/2025 una opción no derivativa para comprar 20.000 acciones a un precio de ejercicio de $6,41 por acción. La opción se otorgó bajo el Plan de Incentivos de Capital 2025 de la compañía y, según el expediente, "quedará 100% consolidada en la fecha de emisión". Tras la concesión, la Sra. Simpson posee directamente 20.000 acciones/opciones declaradas en este Formulario 4.

Sharps Technology Inc.(티커: STSSW)의 이사인 Brenda Baird Simpson은 2025년 8월 22일에 주당 행사가 $6.41로 20,000주를 매수할 수 있는 비파생 옵션을 부여받았습니다. 해당 옵션은 회사의 2025 주식 인센티브 계획에 따라 부여되었으며, 제출서에 따르면 "발행일에 100% 베스팅(완전 귀속)된다"고 명시되어 있습니다. 부여 이후 Simpson 씨는 이 양식(Form 4)에 보고된 20,000주의 주식/옵션을 직접 실질 보유하고 있습니다.

Brenda Baird Simpson, administratrice de Sharps Technology Inc. (symbole : STSSW), s’est vu accorder le 22/08/2025 une option non dérivée d’acheter 20 000 actions au prix d’exercice de 6,41 $ par action. L’option a été attribuée dans le cadre du Plan d’incitation en actions 2025 de la société et, d’après le dépôt, « sera entièrement acquise à la date d’émission ». Après l’attribution, Mme Simpson détient directement 20 000 actions/options bénéficiant d’un intérêt direct, telles que déclarées dans ce Formulaire 4.

Brenda Baird Simpson, Direktorin von Sharps Technology Inc. (Ticker: STSSW), erhielt am 22.08.2025 eine nicht-derivative Option zum Kauf von 20.000 Aktien zu einem Ausübungspreis von $6,41 je Aktie. Die Option wurde im Rahmen des Equity Incentive Plan 2025 des Unternehmens gewährt und wird laut Einreichung „zum Ausgabedatum zu 100 % vesten“. Nach der Gewährung besitzt Frau Simpson direkt begünstigt 20.000 Aktien/Optionen, die in diesem Formular 4 gemeldet sind.

Positive
  • Director grant disclosed: The filing clearly reports a director equity award, supporting transparency.
  • Immediate vesting: The option "will become 100% vested as of the date of issuance," giving the director full ownership rights upon grant.
Negative
  • Potential dilution: Grant of 20,000 options increases potential outstanding shares if exercised (outstanding share count not provided).
  • No rationale disclosed: The filing does not state the business or performance reason for immediate 100% vesting.

Insights

TL;DR: A routine director option grant of 20,000 shares at $6.41 that vests immediately; modestly dilutive but common for compensation.

The filing documents a standard equity compensation action: a director received an option to acquire 20,000 shares at $6.41 under the 2025 Equity Incentive Plan. Immediate 100% vesting aligns the director’s economic interests with shareholders without future service requirements. The grant size appears modest in absolute terms; materiality depends on the company's outstanding share count (not provided). No cash proceeds or derivative conversions were reported beyond the option grant.

TL;DR: Immediate vesting is notable for governance review; disclosure is straightforward and compliant with Section 16 reporting.

The Form 4 properly discloses the director’s award and indicates it was granted under the company’s 2025 Equity Incentive Plan with immediate vesting. From a governance perspective, immediate 100% vesting removes a future service-based retention feature and may warrant board documentation explaining the rationale. The filing is signed and dated, meeting procedural requirements.

Brenda Baird Simpson, membro del consiglio di amministrazione di Sharps Technology Inc. (ticker: STSSW), ha ricevuto in data 22/08/2025 un’opzione non derivativa per acquistare 20.000 azioni al prezzo di esercizio di $6,41 per azione. L’opzione è stata concessa nell’ambito del Piano di Incentivazione Azionaria 2025 della società e, secondo il deposito, "diventerà completamente vestita alla data di emissione". Dopo la concessione, la Sig.ra Simpson detiene direttamente la proprietà beneficiaria di 20.000 azioni/opzioni riportate in questo Modulo 4.

Brenda Baird Simpson, directora de Sharps Technology Inc. (símbolo: STSSW), recibió el 22/08/2025 una opción no derivativa para comprar 20.000 acciones a un precio de ejercicio de $6,41 por acción. La opción se otorgó bajo el Plan de Incentivos de Capital 2025 de la compañía y, según el expediente, "quedará 100% consolidada en la fecha de emisión". Tras la concesión, la Sra. Simpson posee directamente 20.000 acciones/opciones declaradas en este Formulario 4.

Sharps Technology Inc.(티커: STSSW)의 이사인 Brenda Baird Simpson은 2025년 8월 22일에 주당 행사가 $6.41로 20,000주를 매수할 수 있는 비파생 옵션을 부여받았습니다. 해당 옵션은 회사의 2025 주식 인센티브 계획에 따라 부여되었으며, 제출서에 따르면 "발행일에 100% 베스팅(완전 귀속)된다"고 명시되어 있습니다. 부여 이후 Simpson 씨는 이 양식(Form 4)에 보고된 20,000주의 주식/옵션을 직접 실질 보유하고 있습니다.

Brenda Baird Simpson, administratrice de Sharps Technology Inc. (symbole : STSSW), s’est vu accorder le 22/08/2025 une option non dérivée d’acheter 20 000 actions au prix d’exercice de 6,41 $ par action. L’option a été attribuée dans le cadre du Plan d’incitation en actions 2025 de la société et, d’après le dépôt, « sera entièrement acquise à la date d’émission ». Après l’attribution, Mme Simpson détient directement 20 000 actions/options bénéficiant d’un intérêt direct, telles que déclarées dans ce Formulaire 4.

Brenda Baird Simpson, Direktorin von Sharps Technology Inc. (Ticker: STSSW), erhielt am 22.08.2025 eine nicht-derivative Option zum Kauf von 20.000 Aktien zu einem Ausübungspreis von $6,41 je Aktie. Die Option wurde im Rahmen des Equity Incentive Plan 2025 des Unternehmens gewährt und wird laut Einreichung „zum Ausgabedatum zu 100 % vesten“. Nach der Gewährung besitzt Frau Simpson direkt begünstigt 20.000 Aktien/Optionen, die in diesem Formular 4 gemeldet sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Simpson Brenda Baird

(Last) (First) (Middle)
C/O SHARPS TECHNOLOGY, INC.
105 MAXESS ROAD, STE. 124

(Street)
MELVILLE NY 11747

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Option (right to buy) 08/22/2025 P 20,000 A $6.41 20,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Granted pursuant to the Company's 2025 Equity Incentive Plan. The option will become 100% vested as of the date of issuance.
/s/ Brenda Simpson 08/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Brenda Baird Simpson report on Form 4 for STSSW?

She reported a grant of an option to purchase 20,000 shares at an exercise price of $6.41 on 08/22/2025, and the option is 100% vested at issuance.

When was the transaction dated on the Form 4 for STSSW?

The transaction date reported is 08/22/2025.

Under which plan was the STSSW option granted?

The option was granted pursuant to the company's 2025 Equity Incentive Plan.

How many shares does the director beneficially own after the reported transaction?

The Form 4 reports 20,000 shares/options beneficially owned following the transaction.

Does the Form 4 indicate any indirect ownership or joint filing?

The filing indicates direct ownership and that the form was filed by one reporting person.
Sharps Technology Inc

NASDAQ:STSSW

STSSW Rankings

STSSW Latest News

STSSW Latest SEC Filings

STSSW Stock Data

8.81M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE